KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Equity Ratio (2016 - 2025)

Medpace Holdings' Equity Ratio history spans 11 years, with the latest figure at 0.23 for Q4 2025.

  • For Q4 2025, Equity Ratio fell 40.86% year-over-year to 0.23; the TTM value through Dec 2025 reached 0.23, down 40.86%, while the annual FY2025 figure was 0.23, 40.86% down from the prior year.
  • Equity Ratio reached 0.23 in Q4 2025 per MEDP's latest filing, up from 0.17 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.59 in Q1 2021 to a low of 0.11 in Q2 2025.
  • Average Equity Ratio over 5 years is 0.36, with a median of 0.33 recorded in 2023.
  • Peak YoY movement for Equity Ratio: surged 50.3% in 2024, then tumbled 72.43% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.57 in 2021, then tumbled by 50.24% to 0.29 in 2022, then increased by 18.09% to 0.34 in 2023, then rose by 16.48% to 0.39 in 2024, then plummeted by 40.86% to 0.23 in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Equity Ratio are 0.23 (Q4 2025), 0.17 (Q3 2025), and 0.11 (Q2 2025).